Faculty Bibliography

BACKGROUND CONTEXT/BACKGROUND:Obesity has risen to epidemic proportions within the United States. As the rates of obesity have increased, so has its prevalence among patients undergoing adult spinal deformity (ASD) surgery. The effect of obesity on the cost efficiency of corrective procedures for ASD has not been effectively evaluated. PURPOSE/OBJECTIVE:To investigate differences in cost efficiency of ASD surgery for patients stratified by body mass index (BMI). STUDY DESIGN/SETTING/METHODS:Retrospective review of a single center ASD database. PATIENT SAMPLE/METHODS:505 ASD patients OUTCOME MEASURES: Complications, revisions, costs, EuroQol-5D (EQ5D), quality adjusted life years (QALYS), cost per QALY. METHODS:ASD patients (scoliosis≥20°, SVA≥5cm, PT≥25°, or TK ≥60°) ≥18, undergoing ≥4 level fusions were included. Patients were stratified into NIH-defined obesity groups based on their preoperative BMI: underweight 18.5< (U), normal 18.5-24.9 (N), overweight 25.0-29.9 (O), obese I 30.0-34.9 (OI), obese II 35.0-39.9 (OII), and obesity class III 40.0 + (OIII). Total surgery costs for each ASD obesity group were calculated. Costs were calculated using the PearlDiver database, which reflects both private insurance and Medicare reimbursement claims. Overall complications (CC) and major complications (MCC) were assessed according to CMS. DEFINITIONS/BACKGROUND:QALYs and cost per QALY for obesity groups were calculated using an annual 3% discount up to life expectancy (78.7 years). RESULTS:In all, 505 patients met inclusion criteria. Baseline demographics and surgical details were: age 60.8 ± 14.8, 67.6% female, BMI 28.8 ± 7.30, 81.0% posterior approach, 18% combined approach, 10.1 ± 4.2 levels fused, op time 441.2 ± 146.1 minutes, EBL 1903.8 ± 1594.7 cc, LOS 8.7 ± 10.7 days. There were 17 U, 154 N patients, 151 O patients, 100 OI, 51 OII, and 32 OIII patients. Revision rates by obesity group were: 0% U, 3% N patients, 3% O patients, 5% OI, 4% OII, and 6% for OIII patients. The total surgery costs by obesity group were: $48,757.86 U, $49,688.52 N, $47,219.93 O, $50,467.66 OI, $51,189.47 OII, and $53,855.79 OIII. In an analysis of patients with baseline and 1Y EQ5D follow up, the cost per QALY by obesity group was: $153,737.78 U, $229,222.37 N, $290,361.68 O, $493,588.47 OI, $327,876.21 OII, and $171,680.00 OIII. If that benefit was sustained to life expectancy, the cost per QALY was $8,588.70 U, $12,805.72 N, $16,221.32 O, $27,574.77 OI, $18,317.11 OII, and $9,591.06 for OIII. CONCLUSIONS:Among adult spinal deformity patients, those with BMIs in the obesity I, obesity II, or obesity class III range had more expensive total surgery costs. When assessing 1 year cost per quality adjusted life year, obese patients had costs 32% higher than non-obese patients ($224,440.61 vs. $331,048.23). Further research is warranted on the utility of optimizing modifiable preoperative health factors for patients undergoing corrective adult spinal deformity surgery.

BACKGROUND:Spinal degeneration and lumbar flatback deformity can decrease recruitment of protective posterior pelvic tilt when sitting, leading to anterior impingement and increased instability. We aim at analyzing regional and global spinal alignment between sitting and standing to better understand the implications of spinal degeneration and flatback deformity for hip arthroplasty. METHODS:Spinopelvic parameters of patients with full-body sitting-standing stereoradiographs were assessed: lumbar lordosis (LL), spinopelvic tilt (SPT), pelvic incidence minus LL (PI-LL), sagittal vertical axis (SVA), and T1 pelvic angle (TPA). Lumbar spines were classified as normal, degenerative (disc height loss >50%, facet arthropathy, or spondylolisthesis), or flatback (degenerative criteria and PI-LL >10°). Independent t-tests and analysis of variance were used to analyze alignment differences between groups. RESULTS:After propensity matching for age, sex, and hip osteoarthritis grade, 57 patients per group were included (62 ± 11 years, 58% female). Mean standing and sitting SPT, PI-LL, SVA, and TPA increased along the spectrum of disease severity. Increasing severity of disease was associated with decreasing standing and sitting LL. The flatback group demonstrated the greatest sitting SPT, PI-LL, SVA, and TPA. The amount of sitting-to-standing change in SPT, LL, PI-LL, SVA, and TPA decreased along the spectrum of disease severity. CONCLUSION/CONCLUSIONS:Spinal degeneration and lumbar flatback deformity both significantly decrease lower lumbar spine mobility and posterior SPT from standing to sitting in a stepwise fashion. The demonstrated hypomobility in flatback patients likely serves as a pathomechanism for the previously observed increased risk of dislocation in total hip arthroplasty.

OBJECTIVE:Investigate the differences in spine surgery cost for metabolic syndrome patients. METHODS:Included: Patients ≥18, undergoing fusion. Patients were divided into cervical, thoracic, and lumbar groups based on their upper instrumented vertebrae (UIV). Metabolic syndrome patients (MetS) included: BMI >30, DM, dyslipidemia, and HTN. Propensity score matching for invasiveness between Non-MetS and MetS used to assess cost differences. Total surgery costs for MetS and non-MetS ASD patients were compared. QALYs and cost per QALY for UIV groups were calculated. RESULTS:312 invasiveness matched surgeries met inclusion criteria. Baseline demographics and surgical details: age 57.7 ± 14.5, 54% female, BMI 31.1 ± 6.6, 17% anterior approach, 70% posterior approach, 13% combined approach, 3.8 ± 4.1 levels fused. The average costs of surgery between MetS and non-Mets patients was $60,579.30 vs. $52,053.23 (p<0.05). When costs were compared between UIV groups, MetS patients had higher cervical and thoracic surgery costs ($23,203.43 vs $19,153.43, $75,230.05 vs. $65,746.16, all p<0.05) and lower lumbar costs ($31,775.64 vs. $42,643.37, p<0.05). However, the average cost per QALY at 1Y was $639,069.32 for MetS patients and $425,840.30 for non-Mets patients (p<0.05). At life expectancy, the cost per QALY was $45,456.83 vs. $26,026.84 (p<0.05). CONCLUSIONS:When matched by invasiveness, metabolic syndrome patients had an average 16.4% higher surgery costs, 50% higher costs per quality adjusted life years at 1 year, and 75% higher cost per quality adjusted life years at life expectancy. Further research is needed on the possible utility of reducing comorbidities in preoperative patients.

BACKGROUND:Lumbar herniated nucleus pulposus (HNP) is a common spinal pathology often treated by microscopic lumbar discectomy (MLD), though prior reports have not demonstrated which preoperative MRI factors may contribute to significant clinical improvement after MLD. PURPOSE/OBJECTIVE:To analyze the MRI characteristics in patients with HNP that predict meaningful clinical improvement in Health Related Quality of Life scores (HRQoL) after MLD. STUDY DESIGN/SETTING/METHODS:Retrospective clinical and radiological study of patients undergoing MLD for HNP at a single institution over a two-year period. PATIENT SAMPLE/METHODS:88 patients receiving MLD treatment for HNP. OUTCOME MEASURES/METHODS:Cephalocaudal Canal Migration; Canal & HNP Anterior-Posterior (AP) Lengths and Ratio; Canal & HNP Axial Areas and Ratio; Hemi-Canal & Hemi-HNP Axial Areas and Ratio; Disc appearance (black, grey or mixed), Baseline (BL) and 3-Month (3M) postoperative Health Related Quality of Life Scores. METHODS:Patients > 18 years old who received MLD for HNP with BL and 3M HRQoL scores of PROMIS (Physical Function, Pain Interference, and Pain Intensity), ODI, VAS Back, and VAS Leg scores were included. HNP and spinal canal measurements of cephalocaudal migration, AP length, area, hemi-area, and disc appearance were performed using T2 axial and sagittal MRI. HNP measurements were divided by corresponding canal measurements to calculate AP, Area, and Hemi-Area ratios. Using known minimal clinically important differences (MCID) for each ΔHRQoL score, patients were separated into two groups based on whether they reached MCID (MCID+) or did not reach MCID (MCID-). The MCID for PROMIS Pain Intensity was calculated using a decision tree. A linear regression illustrated correlations between PROMIS vs ODI and VAS Back/Leg scores. Independent t-tests and chi [2] tests were utilized to investigate significant differences in HNP measurements between the MCID+ and MCID- groups. RESULTS:± 43.2, p<.04). MCID+ patients had a greater Hemi-Area Ratio than MCID- patients had in 4 out of 6 HRQoL score comparisons (51.8% ± 14.7 vs 43.9% ± 14.9, p<.05). CONCLUSIONS:Patients who met MCID after MLD had larger HNP areas and larger Hemi-HNP Areas than those who did not meet MCID. These patients were also 2.7x more likely to have a grey MRI signal than a mixed or black MRI signal. When accounting for HNP area relative to canal area, patients who met MCID had greater Hemi-HNP canal occupation than patients who did not meet MCID. The results of this study suggest that preoperative MRI parameters can be useful in predicting patient reported improvement after MLD.

BACKGROUND CONTEXT/BACKGROUND:Lateral lumbar interbody fusion is a popular technique used in spine surgery. It is minimally invasive, provides indirect decompression, and allows for coronal plane deformity correction. Despite these benefits, the approach to lateral lumbar interbody fusion has been linked to complications associated with the lumbosacral plexus and vascular anatomy. As a result, vascular surgeons may be recruited for the exposure portion of the procedure. PURPOSE/OBJECTIVE:The purpose of this study was to compare exposure related complication and post-operative (postop) neuropraxia rates between exposure (EXP) and spine surgeon only (SSO) groups when performing the approach for lateral lumbar interbody fusion (LLIF). STUDY DESIGN/SETTING/METHODS:Retrospective analysis of patients treated at a single institution PATIENT SAMPLE: Patients undergoing LLIF procedures between 2012-2018 OUTCOME MEASURES: Operative time, estimated blood loss, fluoroscopy, length of stay, intra- and post-operative complications, and physiologic measures including pre- and post-operative motor examinations and unresolved neuropraxia METHODS: Patients who underwent LLIF were separated into EXP and SSO groups based on the presence or absence of vascular/general surgeon during the approach. The entire clinical history of patients with a decrease in pre and postop motor examination were reviewed for the presence of neuropraxia. All other intra- and postop exposure related complications were recorded for comparison. PSM was performed to account for age, Charlston Comorbity Index (CCI) % LLIFs including L4-L5, and number levels fused. Independent T-test and Chi-squared analyses were used to identify significant differences between EXP and SSO groups. Statistical significance was set at p<0.05. RESULTS:Two hundred seventy-five patients underwent LLIF procedures, 155 SSO and 120 EXP. Post-operatively, 26 patients (11.1%) experienced a drop in any MRC score, and two patients (0.7%) experience unresolved quadriceps palsies. The mean recovery time for MRC scores was 84.4 days. Other complications included 2 pneumothoraces (0.7%), 1 iliac vein injury (0.4%), 14 cases of ileus (5.1%), 3 pulmonary emboli (1.1%), 2 deep vein thrombosis (0.7%), 3 cases of abdominal wall paresis (1.1%), and one abdominal hematoma (0.4%). After PSM, demographics including age, gender, BMI, CCI, levels fused and operative time were similar between cohorts. Twenty patients had changes in pre- to postop motor scores (SSO 9.4%, EXP 12.4%, p>0.05). Iliopsoas motor scores decreased at the highest rate (EXP 12.4%, 8.2% SSO, p>0.05) followed by quadriceps (EXP 5.2%, SSO 4.7%, p>0.05). One SSO patient's postop course was complicated by a foot drop but returned to baseline within 1-year. One patient in EXP group developed an unresolved quadriceps palsy (EXP 1.0%, SSO 0.0% p>0.05). Intra-op exposure complications included one pneumothorax (EXP 1.0%, SSO 0.0%, p>0.05). There were no differences in PE/DVT, Ileus, or LOS. In the EXP cohort, three patients experienced abdominal wall paresis (EXP 2.9%, SSO 0.00%, p=0.246). CONCLUSIONS:Comparing the LLIF exposures performed by EXP and SSO, we found no significant difference in the rates of complications. Additional research is needed to determine the etiology of the abdominal wall complications. In conclusion, neuropraxia- and approach-related complications are similarly low between exposure and spine surgeons.

STUDY DESIGN/UNASSIGNED:Retrospective clinical review. OBJECTIVE/UNASSIGNED:To assess the use of intraoperative computed tomography (CT) image-guided navigation (IGN) and robotic assistance in posterior lumbar surgery and their relationship with patient radiation exposure and perioperative outcomes. METHODS/UNASSIGNED:Patients ≥18 years old undergoing 1- to 2-level transforaminal lateral interbody fusion in 12-month period were included. Chart review was performed for pre- and intraoperative data on radiation dose and perioperative outcomes. All radiation doses are quantified in milliGrays (mGy). Univariate analysis and multivariate logistic regression analysis were utilized for categorical variables. One-way analysis of variance with post hoc Tukey test was used for continuous variables. RESULTS/UNASSIGNED:= .313, .051, and .644, respectively). CONCLUSION/UNASSIGNED:IGN and robotic assistance in posterior lumbar fusion were associated with higher intraoperative and total-procedure radiation exposure than open cases without IGN/robotics, but significantly less than MIS without IGN/robotics, without differences in perioperative outcomes. Fluoro-MIS procedures reported highest radiation exposure to patient, and of equal concern is that the proportion of total radiation dose also applied to the surgeon and operating room staff in fluoro-MIS group is higher than in IGN/robotics and open groups.

STUDY DESIGN/METHODS:Single-center retrospective study. OBJECTIVE:Investigate how differing degrees of PI modulate the recruitment of pelvic tilt (PT) in response to similar amounts of sagittal malalignment as measured by T1-Pelvic Angle (TPA). SUMMARY OF BACKGROUND DATA/BACKGROUND:Past research has shown that some patients do not recruit PT in response to sagittal malalignment. Given the anatomic relationship between PI and PT, we sought to determine whether differing PI is associated with variable recruitment of PT. METHODS:Single-center retrospective study of 2077 patients undergoing full body radiographs and TPA>10°. Five groups of patients (Very Low, Low, Average, High, and Very High PI) were defined utilizing PI ranges on a gaussian distribution. Linear regression (LR) evaluated correlation of TPA to PT within each PI group. Multivariate LR evaluated whether correlation between TPA and PT differed between each PI group. RESULTS:Mean PT increased with increasing levels of PI (p < 0.05). Within the full cohort, PT correlated with TPA (r = 0.80, p < 0.001). Multivariate LR revealed significant differences between slopes and intercepts of the linear relationship between PT and TPA within the PI groups. Compared to patients with an average PI, patients with Very Low PI had 3.4° lower PT while holding TPA constant (p < 0.001). Further, patients with Very High PI displayed a PT of 1.9° higher than patients with an Average PI while holding TPA constant (p = 0.01). A similar difference of -1.8°, and 1.2° with respect to the Average PI group was observed in the Low and High PI groups, respectively (p < 0.001). Means and standard deviations of PT at varying levels of TPA were defined for PI groups. CONCLUSIONS:This is the first study which demonstrated that PI is associated with varied recruitment of PT while maintaining constant sagittal malalignment. The results reported herein are intended to allow surgeons to assess a patient's magnitude of compensatory PT for an individual patient's PI. LEVEL OF EVIDENCE/METHODS:3.

STUDY DESIGN/METHODS:Retrospective analysis OBJECTIVE.: Determine whether deformity corrections should vary by pelvic incidence (PI). SUMMARY OF BACKGROUND DATA/BACKGROUND:Alignment targets for deformity correction have been reported for various radiographic parameters. The T1 pelvic-angle (TPA) has gained in applications for ASD surgical-planning since it directly measures spinal alignment separate from pelvic- and lower-extremity compensation. Recent studies have demonstrated that ASD corrections should be age specific. METHODS:A prospective database of consecutive ASD patients was analyzed in conjunction with a normative spine database. Clinical measures of disability included the Oswestry Disability Index (ODI) and SF-36 Physical Component Score (PCS). Baseline relationships between TPA, age, PI and ODI/SF-36 PCS scores were analyzed in the ASD and asymptomatic patients. Linear regression modeling was used to determine alignment targets based on PI and age-specific normative SF-36-PCS values. RESULTS:903 ASD patients (mean 53.7y) and 111 normative subjects (mean 50.7y) were included. Patients were subanalyzed by PI: low, medium, high (<40, 40-75, >75); and age: elderly(>65y, n = 375) middle age(45-65y, n = 387) and young(18-45y, n = 141). TPA and SRS-Schwab parameters correlated with age and PI in ASD and normative subjects (r = .42, p < .0001). ODI correlated with PCS(r = .71, p < .0001). Linear regression analysis using age-normative SF-36-PCS values demonstrated that ideal spinopelvic alignment is less strict with increasing PI and age. CONCLUSIONS:Targets for ASD correction should vary by age and PI. This is demonstrated in both asymptomatic and ASD subjects. Using age-normative SF-36 PCS values, alignment targets are described for different age and PI categories. High-PI patients do not require as rigorous realignments to attain age-specific normative levels of health status. As such, sagittal spinal alignment targets increase with increasing age as well as PI. LEVEL OF EVIDENCE/METHODS:3.

STUDY DESIGN/UNASSIGNED:This was a single-center retrospective review. OBJECTIVES/UNASSIGNED:To explore how age and gender affect PROMIS scores compared with traditional health-related quality of life (HRQL) in spine patients. METHODS/UNASSIGNED:Patients presenting with a primary complaint of back pain (BP) or neck pain (NP) were included. Legacy HRQLs were Oswestry Disability Index (ODI), Neck Disability Index (NDI), and Visual Analogue Scale (VAS). PROMIS Physical Function (PF), Pain Intensity (Int), and Pain Interference (Inf) were also administered to patients in a clinical setting. Patients were grouped by chief complaint, age (18-44, 45-64, 65+ years) and gender. Two parallel analyses were conducted to identify the effects of age and gender on patient-reported outcomes. Age groups were compared after propensity-score matching by VAS-pain and gender. Separately, genders were compared after propensity-score matching by age and VAS-pain. RESULTS/UNASSIGNED:= .022) but not PROMIS-Int or PROMIS-Inf. CONCLUSIONS/UNASSIGNED:Age and gender confound traditional HRQLs as well as PROMIS domains. However, PROMIS offers age and gender-specific scores, which traditional HRQLs lack.

Metabolic syndrome is a clustering of clinical findings defined in the literature including hypertension, high glucose, abdominal obesity, high triglyceride, and low high-density lipoprotein cholesterol levels. The purpose of this study was to assess perioperative outcomes in patients undergoing spine fusion surgery with (MetS) and without (no-MetS) a history of metabolic syndrome. Included: Patients ≥18 yrs old undergoing spine fusion procedures diagnosed with MetS components with BL and 1-year follow-up were isolated in a single-center database. Patients in the two groups were propensity score matched for levels fused. 250 spine fusion patients (58 yrs, 52.2%F, 39.0 kg/m²) with an average CCI of 1.92 were analyzed. 125 patients were classified with MetS (60.2 yrs, 52%F, CCI: 3.2). MetS patients were significantly older (p = 0.012). MetS patients underwent significantly more open (Met-S: 78.4% vs No-MetS: 45.6%, p < 0.001) and posterior approached procedures (Met-S: 60.8% vs No-MetS: 47.2%, p = 0.031). Mean operative time: 272.4 ± 150 min (MetS: 288.1 min vs. no-MetS: 259.7; p = 0.089). Average length of stay: 4.6 days (MetS: 5.27 vs no-MetS: 3.95; p = 0.095). MetS patients had more post-operative complications (29.6% vs. 18.4%; p = 0.038), specifically neuro (6.4% vs 2.4%), pulmonary (4% vs. 1.6%), and urinary (4.8% vs 2.4%) complications. Binary logistic regression analyses found that MetS was an independent risk factor for post-operative complications (OR: 1.865 [1.030-3.375], p = 0.040). With longer surgeries and greater open-exposure types, MetS patients were at greater risk for complications, despite controlling for total number of levels fused. Surgeons should be aware of the increased threat to spine surgery patients with metabolic syndrome in order to optimize surgical decision-making.